Report Overview
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. The action of eCG is similar to the action of Follicle- Stimulating Hormone (FSH), which is produced by the animals' anterior pituitary gland. It stimulates the follicles of the ovaries to produce mature ova (eggs), and it promotes the outward signs of estrus (heat).
The global Equine Chorionic Gonadotropin (eCG) for Injection market size was estimated at USD 257 million in 2023 and is projected to reach USD 391.91 million by 2032, exhibiting a CAGR of 4.80% during the forecast period.
North America Equine Chorionic Gonadotropin (eCG) for Injection market size was estimated at USD 72.59 million in 2023, at a CAGR of 4.11% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Equine Chorionic Gonadotropin (eCG) for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Equine Chorionic Gonadotropin (eCG) for Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Equine Chorionic Gonadotropin (eCG) for Injection market in any manner.
Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
MSD Animal Health
Ceva Sant� Animale
Syntex SA
Bioveta
Ningbo Sansheng Biological Technology
Ningbo Second Hormone Factory
Chifeng Bo-en Pharmaceutical
Guangzhou Vbio-Pharma
JALLY
Ningbo Creator Animal Pharmaceutical
Market Segmentation (by Type)
1000 IU/Unit
5000 IU/Unit
Others
Market Segmentation (by Application)
Pig
Cattle
Sheep
Horse
Other Animals
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Equine Chorionic Gonadotropin (eCG) for Injection Market
� Overview of the regional outlook of the Equine Chorionic Gonadotropin (eCG) for Injection Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Equine Chorionic Gonadotropin (eCG) for Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Equine Chorionic Gonadotropin (eCG) for Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Equine Chorionic Gonadotropin (eCG) for Injection
1.2 Key Market Segments
1.2.1 Equine Chorionic Gonadotropin (eCG) for Injection Segment by Type
1.2.2 Equine Chorionic Gonadotropin (eCG) for Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Equine Chorionic Gonadotropin (eCG) for Injection Market Overview
2.1 Global Market Overview
2.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Equine Chorionic Gonadotropin (eCG) for Injection Market Competitive Landscape
3.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Manufacturers (2019-2025)
3.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Manufacturers (2019-2025)
3.3 Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Equine Chorionic Gonadotropin (eCG) for Injection Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Sales Sites, Area Served, Product Type
3.6 Equine Chorionic Gonadotropin (eCG) for Injection Market Competitive Situation and Trends
3.6.1 Equine Chorionic Gonadotropin (eCG) for Injection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Equine Chorionic Gonadotropin (eCG) for Injection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Equine Chorionic Gonadotropin (eCG) for Injection Industry Chain Analysis
4.1 Equine Chorionic Gonadotropin (eCG) for Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Equine Chorionic Gonadotropin (eCG) for Injection Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Equine Chorionic Gonadotropin (eCG) for Injection Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2025)
6.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Market Share by Type (2019-2025)
6.4 Global Equine Chorionic Gonadotropin (eCG) for Injection Price by Type (2019-2025)
7 Equine Chorionic Gonadotropin (eCG) for Injection Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Sales by Application (2019-2025)
7.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size (M USD) by Application (2019-2025)
7.4 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth Rate by Application (2019-2025)
8 Equine Chorionic Gonadotropin (eCG) for Injection Market Consumption by Region
8.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region
8.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region
8.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region
8.2 North America
8.2.1 North America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Equine Chorionic Gonadotropin (eCG) for Injection Market Production by Region
9.1 Global Production of Equine Chorionic Gonadotropin (eCG) for Injection by Region (2019-2025)
9.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Region (2019-2025)
9.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Equine Chorionic Gonadotropin (eCG) for Injection Production
9.4.1 North America Equine Chorionic Gonadotropin (eCG) for Injection Production Growth Rate (2019-2025)
9.4.2 North America Equine Chorionic Gonadotropin (eCG) for Injection Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Equine Chorionic Gonadotropin (eCG) for Injection Production
9.5.1 Europe Equine Chorionic Gonadotropin (eCG) for Injection Production Growth Rate (2019-2025)
9.5.2 Europe Equine Chorionic Gonadotropin (eCG) for Injection Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Equine Chorionic Gonadotropin (eCG) for Injection Production (2019-2025)
9.6.1 Japan Equine Chorionic Gonadotropin (eCG) for Injection Production Growth Rate (2019-2025)
9.6.2 Japan Equine Chorionic Gonadotropin (eCG) for Injection Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Equine Chorionic Gonadotropin (eCG) for Injection Production (2019-2025)
9.7.1 China Equine Chorionic Gonadotropin (eCG) for Injection Production Growth Rate (2019-2025)
9.7.2 China Equine Chorionic Gonadotropin (eCG) for Injection Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 MSD Animal Health
10.1.1 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
10.1.2 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
10.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Product Market Performance
10.1.4 MSD Animal Health Business Overview
10.1.5 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection SWOT Analysis
10.1.6 MSD Animal Health Recent Developments
10.2 Ceva Sant� Animale
10.2.1 Ceva Sant� Animale Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
10.2.2 Ceva Sant� Animale Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
10.2.3 Ceva Sant� Animale Equine Chorionic Gonadotropin (eCG) for Injection Product Market Performance
10.2.4 Ceva Sant� Animale Business Overview
10.2.5 Ceva Sant� Animale Equine Chorionic Gonadotropin (eCG) for Injection SWOT Analysis
10.2.6 Ceva Sant� Animale Recent Developments
10.3 Syntex SA
10.3.1 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
10.3.2 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
10.3.3 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Product Market Performance
10.3.4 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection SWOT Analysis
10.3.5 Syntex SA Business Overview
10.3.6 Syntex SA Recent Developments
10.4 Bioveta
10.4.1 Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
10.4.2 Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
10.4.3 Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Product Market Performance
10.4.4 Bioveta Business Overview
10.4.5 Bioveta Recent Developments
10.5 Ningbo Sansheng Biological Technology
10.5.1 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
10.5.2 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
10.5.3 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Product Market Performance
10.5.4 Ningbo Sansheng Biological Technology Business Overview
10.5.5 Ningbo Sansheng Biological Technology Recent Developments
10.6 Ningbo Second Hormone Factory
10.6.1 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
10.6.2 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
10.6.3 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Product Market Performance
10.6.4 Ningbo Second Hormone Factory Business Overview
10.6.5 Ningbo Second Hormone Factory Recent Developments
10.7 Chifeng Bo-en Pharmaceutical
10.7.1 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
10.7.2 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
10.7.3 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Market Performance
10.7.4 Chifeng Bo-en Pharmaceutical Business Overview
10.7.5 Chifeng Bo-en Pharmaceutical Recent Developments
10.8 Guangzhou Vbio-Pharma
10.8.1 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
10.8.2 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
10.8.3 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Product Market Performance
10.8.4 Guangzhou Vbio-Pharma Business Overview
10.8.5 Guangzhou Vbio-Pharma Recent Developments
10.9 JALLY
10.9.1 JALLY Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
10.9.2 JALLY Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
10.9.3 JALLY Equine Chorionic Gonadotropin (eCG) for Injection Product Market Performance
10.9.4 JALLY Business Overview
10.9.5 JALLY Recent Developments
10.10 Ningbo Creator Animal Pharmaceutical
10.10.1 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
10.10.2 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
10.10.3 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Market Performance
10.10.4 Ningbo Creator Animal Pharmaceutical Business Overview
10.10.5 Ningbo Creator Animal Pharmaceutical Recent Developments
11 Equine Chorionic Gonadotropin (eCG) for Injection Market Forecast by Region
11.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast
11.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Country
11.2.3 Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Region
11.2.4 South America Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Equine Chorionic Gonadotropin (eCG) for Injection by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Equine Chorionic Gonadotropin (eCG) for Injection by Type (2025-2032)
12.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Equine Chorionic Gonadotropin (eCG) for Injection by Type (2025-2032)
12.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Forecast by Application (2025-2032)
12.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT) Forecast by Application
12.2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Equine Chorionic Gonadotropin (eCG) for Injection Market Size Comparison by Region (M USD)
Table 5. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Chorionic Gonadotropin (eCG) for Injection as of 2022)
Table 10. Global Market Equine Chorionic Gonadotropin (eCG) for Injection Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Sales Sites and Area Served
Table 12. Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Product Type
Table 13. Global Equine Chorionic Gonadotropin (eCG) for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Equine Chorionic Gonadotropin (eCG) for Injection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Equine Chorionic Gonadotropin (eCG) for Injection Market Challenges
Table 22. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (K MT)
Table 23. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Type (M USD)
Table 24. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT) by Type (2019-2025)
Table 25. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2025)
Table 26. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size (M USD) by Type (2019-2025)
Table 27. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Share by Type (2019-2025)
Table 28. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (USD/MT) by Type (2019-2025)
Table 29. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT) by Application
Table 30. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Application
Table 31. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2025) & (K MT)
Table 32. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2025)
Table 33. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2025) & (M USD)
Table 34. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Application (2019-2025)
Table 35. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth Rate by Application (2019-2025)
Table 36. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2019-2025) & (K MT)
Table 37. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region (2019-2025)
Table 38. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2025) & (K MT)
Table 39. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2019-2025) & (K MT)
Table 41. South America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2019-2025) & (K MT)
Table 43. Global Equine Chorionic Gonadotropin (eCG) for Injection Production (K MT) by Region (2019-2025)
Table 44. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Region (2019-2025)
Table 46. Global Equine Chorionic Gonadotropin (eCG) for Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Equine Chorionic Gonadotropin (eCG) for Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Equine Chorionic Gonadotropin (eCG) for Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Equine Chorionic Gonadotropin (eCG) for Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Equine Chorionic Gonadotropin (eCG) for Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
Table 52. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
Table 53. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. MSD Animal Health Business Overview
Table 55. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection SWOT Analysis
Table 56. MSD Animal Health Recent Developments
Table 57. Ceva Sant� Animale Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
Table 58. Ceva Sant� Animale Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
Table 59. Ceva Sant� Animale Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Ceva Sant� Animale Business Overview
Table 61. Ceva Sant� Animale Equine Chorionic Gonadotropin (eCG) for Injection SWOT Analysis
Table 62. Ceva Sant� Animale Recent Developments
Table 63. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
Table 64. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
Table 65. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection SWOT Analysis
Table 67. Syntex SA Business Overview
Table 68. Syntex SA Recent Developments
Table 69. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
Table 70. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
Table 71. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Bioveta Business Overview
Table 73. Bioveta Recent Developments
Table 74. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
Table 75. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
Table 76. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Ningbo Sansheng Biological Technology Business Overview
Table 78. Ningbo Sansheng Biological Technology Recent Developments
Table 79. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
Table 80. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
Table 81. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Ningbo Second Hormone Factory Business Overview
Table 83. Ningbo Second Hormone Factory Recent Developments
Table 84. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
Table 85. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
Table 86. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Chifeng Bo-en Pharmaceutical Business Overview
Table 88. Chifeng Bo-en Pharmaceutical Recent Developments
Table 89. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
Table 90. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
Table 91. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Guangzhou Vbio-Pharma Business Overview
Table 93. Guangzhou Vbio-Pharma Recent Developments
Table 94. JALLY Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
Table 95. JALLY Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
Table 96. JALLY Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. JALLY Business Overview
Table 98. JALLY Recent Developments
Table 99. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Basic Information
Table 100. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Overview
Table 101. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Ningbo Creator Animal Pharmaceutical Business Overview
Table 103. Ningbo Creator Animal Pharmaceutical Recent Developments
Table 104. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Region (2025-2032) & (K MT)
Table 105. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Country (2025-2032) & (K MT)
Table 107. North America Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Country (2025-2032) & (K MT)
Table 109. Europe Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Region (2025-2032) & (K MT)
Table 111. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Country (2025-2032) & (K MT)
Table 113. South America Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Type (2025-2032) & (K MT)
Table 117. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Equine Chorionic Gonadotropin (eCG) for Injection Price Forecast by Type (2025-2032) & (USD/MT)
Table 119. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT) Forecast by Application (2025-2032)
Table 120. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Equine Chorionic Gonadotropin (eCG) for Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size (M USD), 2019-2032
Figure 5. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size (M USD) (2019-2032)
Figure 6. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Country (M USD)
Figure 11. Equine Chorionic Gonadotropin (eCG) for Injection Sales Share by Manufacturers in 2023
Figure 12. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Share by Manufacturers in 2023
Figure 13. Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Equine Chorionic Gonadotropin (eCG) for Injection Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Equine Chorionic Gonadotropin (eCG) for Injection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Type
Figure 18. Sales Market Share of Equine Chorionic Gonadotropin (eCG) for Injection by Type (2019-2025)
Figure 19. Sales Market Share of Equine Chorionic Gonadotropin (eCG) for Injection by Type in 2023
Figure 20. Market Size Share of Equine Chorionic Gonadotropin (eCG) for Injection by Type (2019-2025)
Figure 21. Market Size Market Share of Equine Chorionic Gonadotropin (eCG) for Injection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Application
Figure 24. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2025)
Figure 25. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application in 2023
Figure 26. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Application (2019-2025)
Figure 27. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Application in 2023
Figure 28. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth Rate by Application (2019-2025)
Figure 29. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region (2019-2025)
Figure 30. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country in 2023
Figure 32. U.S. Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Equine Chorionic Gonadotropin (eCG) for Injection Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Equine Chorionic Gonadotropin (eCG) for Injection Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country in 2023
Figure 37. Germany Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region in 2023
Figure 44. China Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (K MT)
Figure 50. South America Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country in 2023
Figure 51. Brazil Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Equine Chorionic Gonadotropin (eCG) for Injection Production Market Share by Region (2019-2025)
Figure 62. North America Equine Chorionic Gonadotropin (eCG) for Injection Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Equine Chorionic Gonadotropin (eCG) for Injection Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Equine Chorionic Gonadotropin (eCG) for Injection Production (K MT) Growth Rate (2019-2025)
Figure 65. China Equine Chorionic Gonadotropin (eCG) for Injection Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share Forecast by Type (2025-2032)
Figure 70. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Application (2025-2032)
Figure 71. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share Forecast by Application (2025-2032)
